CDSI News
Dr. Phillips speaks at Blavatnik U.S.–Israel Scientific Forum on Genome Medicine
We are proud to announce that Dr. Elizabeth Phillips was recently an invited speaker and participant at the esteemed Blavatnik U.S.–Israel Scientific Forum on Genome Medicine, hosted by the…
Multispecialty Center Targets Adverse Drug Reactions
Drug-safety expert and CDSI director Elizabeth Phillips, M.D., addresses her multidisciplinary mission to make drugs safer and more accessible.
Researchers, including CDSI member Dr. Cosby Stone, seek biomarkers to identify patients with chemotherapy allergies
Physicians in the Drug Allergy Clinic at Vanderbilt University Medical Center are studying how to best help patients tolerate allergy-inducing chemotherapy drugs.
Multiomic single-cell sequencing defines tissue-specific responses in Stevens-Johnson syndrome and toxic epidermal necrolysis
Understanding Life-Threatening Medication-induced Skin Reactions at a “Single-cell” level: How Our Immune System Turns Against Us